- Home
- MRT vs SGMO Comparison
MRT vs SGMO Comparison
Compare MRT & SGMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MRT | SGMO |
|---|---|---|
| Founded | 2018 | 1995 |
| Country | Turkey | United States |
| Employees | N/A | N/A |
| Industry | Rental/Leasing Companies | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 164.5M | 141.2M |
| IPO Year | 2021 | 2000 |
Fundamental Metrics
Financial Performance| Metric | MRT | SGMO |
|---|---|---|
| Price | $2.18 | $0.41 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 4 |
| Target Price | ★ $6.00 | $5.75 |
| AVG Volume (30 Days) | 21.1K | ★ 3.9M |
| Earning Date | 01-01-0001 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 66.89 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $36,567,000.00 |
| Revenue This Year | $84.47 | $4.79 |
| Revenue Next Year | $94.45 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 88.60 |
| 52 Week Low | $1.97 | $0.35 |
| 52 Week High | $3.70 | $1.04 |
Technical Indicators
Market Signals| Indicator | MRT | SGMO |
|---|---|---|
| Relative Strength Index (RSI) | 56.72 | 49.23 |
| Support Level | $2.12 | $0.36 |
| Resistance Level | $2.15 | $0.56 |
| Average True Range (ATR) | 0.07 | 0.04 |
| MACD | 0.02 | -0.00 |
| Stochastic Oscillator | 53.13 | 23.65 |
Price Performance
Historical ComparisonAbout MRT Marti Technologies Inc.
Marti Technologies Inc is a mobility app, offering multiple transportation services to its riders. Marti operates a ride-hailing service that matches riders with car, motorcycle, and taxi drivers, and operates a large fleet of rental e-mopeds, e-bikes, and e-scooters. All of Marti's offerings are serviced by proprietary software systems and IoT infrastructure.
About SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.